Form D — Allyx Therapeutics, Inc.
0001865257-26-000004 · filed 2026-05-11
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $29,999,999
- Total sold
- $26,427,730
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Allyx Therapeutics, Inc.
- CIK
- 1865257
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 555 Long Wharf Drive
NEW HAVEN, CT 06511 - Phone
- (908) 432-2845
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Gregory P Ho · DirectorNew York, NY Find on LinkedIn ↗
-
Robert A Bettigole · DirectorNew Haven, CT Find on LinkedIn ↗
-
Timothy Siegert · Executive OfficerNew Haven, CT Find on LinkedIn ↗
-
Kevin L. Rakin · DirectorWestport, CT Find on LinkedIn ↗
-
Stephen Bloch · Executive OfficerNew Haven, CT Find on LinkedIn ↗
-
Stephen Strittmatter · DirectorNew Haven, CT Find on LinkedIn ↗
-
Paul Fonteyne · DirectorNew Haven, CT Find on LinkedIn ↗
View original on SEC EDGAR.